Clinical Trial Update: Clinical Equivalence of Budesonide HFA MDI Versus Budesonide Turbuhaler in Mild to Moderate Chinese Asthma Patients [Phase 4]

View source ↗

Summary

A Phase 4 trial reports clinical equivalence between Budesonide HFA MDI and Budesonide Turbuhaler in mild to moderate Chinese asthma patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Budesonide HFA MDI (budesonide)
• Budesonide Turbuhaler (budesonide)

Snippet

Sponsor: Intech Biopharm Ltd. | Conditions: Asthma | Phase 4 | Status: COMPLETED